The present invention provides compounds that modulate biological metals and to pharmaceutical compositions containing such compounds. The invention particularly relates to imidazo[1,5-a]pyridine compounds that modulate iron and are useful for the treatment of diseases, particularly neurological diseases such as Parkinson's disease (PD), Alzheimer's 5 disease (AD), Alzheimer-type dementia, Huntington's disease (HD), amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD) and multiple system atrophy (MSA).
本发明提供了调节
生物金属的化合物,并含有这些化合物的药物组合物。该发明特别涉及调节
铁的
咪唑[1,5-a]
吡啶化合物,用于治疗疾病,特别是神经系统疾病,如帕
金森病(PD)、阿尔茨海默病(AD)、阿尔茨海默型痴呆、亨廷顿病(HD)、肌萎缩侧索硬化症(ALS)、额颞叶痴呆(FTD)和多系统萎缩(M
SA)。